The Economist magazine is seldom shy about telling companies and government’s what to do. The know-it-all tone can be annoying but at least they don’t try to hide behind a claim of objectivity.
But it appears that when it comes to addressing Merck’s woes (Merck’s Migraine in the December 3 issue) they –like others– are at a loss. Here’s the best they can come up with on how to improve R and D productivity:
â€œSome sort of x-factor is needed to turn research reliably into products.â€
Indeed.December 7, 2005